Product Recalls in Connecticut

Product recalls affecting Connecticut — including food, drugs, consumer products, medical devices, and vehicles distributed to Connecticut. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,648 recalls have been distributed to Connecticut in the last 12 months.

51,038 total recalls
2,648 in last 12 months

Showing 42014220 of 13,380 recalls

DrugDecember 17, 2020· SCA Pharmaceuticals

Recalled Item: fentaNYL 100 mcg/2mL Injection for IV or IM Use Recalled by SCA...

The Issue: Lack of Assurance of Sterility; potential for a defective syringe cap,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2020· SCA Pharmaceuticals

Recalled Item: Atropine Sulfate Injection Recalled by SCA Pharmaceuticals Due to Lack of...

The Issue: Lack of Assurance of Sterility; potential for a defective syringe cap,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2020· SCA Pharmaceuticals

Recalled Item: Lidocaine HCl 1% 10 mL (10mg/ml) Recalled by SCA Pharmaceuticals Due to Lack...

The Issue: Lack of Assurance of Sterility; potential for a defective syringe cap,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2020· SCA Pharmaceuticals

Recalled Item: neostigmine methylsulfate 5 mg/5 mL Recalled by SCA Pharmaceuticals Due to...

The Issue: Lack of Assurance of Sterility; potential for a defective syringe cap,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2020· SCA Pharmaceuticals

Recalled Item: SUCcinylcholine Chloride 100 mg/5mL Recalled by SCA Pharmaceuticals Due to...

The Issue: Lack of Assurance of Sterility; potential for a defective syringe cap,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2020· SCA Pharmaceuticals

Recalled Item: Lidocaine HCl 2% 5 mL Recalled by SCA Pharmaceuticals Due to Lack of...

The Issue: Lack of Assurance of Sterility; potential for a defective syringe cap,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 16, 2020· US Compounding Inc

Recalled Item: Succinylcholine Chloride PF Inj. 200 mg/10 mL Recalled by US Compounding Inc...

The Issue: Labeling: Incorrect or Missing lot and/or expiration date: The lot number...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 14, 2020· SCA Pharmaceuticals, Inc.

Recalled Item: Vasopressin 20 Units added to 0.9% Sodium Chloride 100 mL Rx Only Recalled...

The Issue: Subpotent drug.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 14, 2020· CIPLA

Recalled Item: Azacitidine for Injection 100 mg/vial For Subcutaneous and Intravenous Use...

The Issue: cGMP deviations: Vials may not be sealed correctly affecting sterility.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 10, 2020· Fresenius Kabi USA, LLC

Recalled Item: Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection Recalled by...

The Issue: Subpotent Drug: Low out-of-specification assay results for the epinephrine...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 9, 2020· Biogen MA Inc.

Recalled Item: Vumerity (diroximel fumarate) delayed-release capsule Recalled by Biogen MA...

The Issue: Failed dissolution specifications: out-of-specification test results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 9, 2020· Akebia Therapeutics dba Keryx Biopharmaceutials, Inc

Recalled Item: Auryxia (ferric citrate) tablets Recalled by Akebia Therapeutics dba Keryx...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 9, 2020· Morton Grove Pharmaceuticals, Inc.

Recalled Item: Hydroxyzine Hydrochloride Oral Solution Recalled by Morton Grove...

The Issue: Failed Impurities/Degradation Specification: OOS for the following - unknown...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 8, 2020· Shilpa Medicare Limited

Recalled Item: Busulfan Injection 60 mg/10 mL (6 mg/mL) Recalled by Shilpa Medicare Limited...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 8, 2020· Shilpa Medicare Limited

Recalled Item: Imatinib Mesylate Tablets 100 mg Recalled by Shilpa Medicare Limited Due to...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 8, 2020· Shilpa Medicare Limited

Recalled Item: Imatinib Mesylate Tablets 400 mg Recalled by Shilpa Medicare Limited Due to...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 8, 2020· Shilpa Medicare Limited

Recalled Item: Azacitidine for Injection 100 mg/vial Recalled by Shilpa Medicare Limited...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 8, 2020· Shilpa Medicare Limited

Recalled Item: Docetaxel Injection USP 160 mg/8mL (20 mg/mL) Recalled by Shilpa Medicare...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 8, 2020· Shilpa Medicare Limited

Recalled Item: Azacitidine for Injection 100 mg/vial Recalled by Shilpa Medicare Limited...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 7, 2020· AVKARE Inc.

Recalled Item: TraZODONE Hydrochloride Tablets USP 100 mg Recalled by AVKARE Inc. Due to...

The Issue: Product mix-up: Bottles of sildenafil and trazodone were inadvertently...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund